Legal & General Group PLC Y M Abs Therapeutics, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 37,695 shares of YMAB stock, worth $419,922. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,695

Previous 37,695 -0.0%

Holding current value

$419,922

Previous $494,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$9.95 - $15.39 $11,084 - $17,144	1,114 Added 3.05%	37,695 $494,000
Q2 2024 Aug 14, 2024	BUY	$11.6 - $17.25 $385,932 - $573,907	33,270 Added 1004.83%	36,581 $441,000
Q1 2024 May 14, 2024	SELL	$6.57 - $18.69 $2,358 - $6,709	-359 Reduced 9.78%	3,311 $53,000
Q4 2023 Feb 15, 2024	BUY	$4.88 - $7.42 $1,459 - $2,218	299 Added 8.87%	3,670 $25,000
Q3 2023 Nov 14, 2023	SELL	$4.86 - $7.23 $2,673 - $3,976	-550 Reduced 14.03%	3,371 $18,000
Q2 2023 Aug 14, 2023	SELL	$5.68 - $10.34 $2,891 - $5,263	-509 Reduced 11.49%	3,921 $26,000
Q1 2023 May 15, 2023	SELL	$2.83 - $5.11 $31,257 - $56,439	-11,045 Reduced 71.37%	4,430 $22,000
Q3 2022 Nov 14, 2022	SELL	$13.96 - $19.67 $83,662 - $117,882	-5,993 Reduced 27.92%	15,475 $223,000
Q2 2022 Aug 22, 2022	BUY	$8.22 - $15.13 $94,275 - $173,525	11,469 Added 114.7%	21,468 $325,000
Q4 2021 Feb 14, 2022	BUY	$15.51 - $29.31 $1,318 - $2,491	85 Added 0.86%	9,999 $162,000
Q3 2021 Nov 15, 2021	BUY	$27.47 - $37.31 $139,630 - $189,646	5,083 Added 105.22%	9,914 $282,000
Q2 2021 Aug 12, 2021	BUY	$25.45 - $37.64 $7,711 - $11,404	303 Added 6.69%	4,831 $163,000
Q1 2021 May 17, 2021	BUY	$29.16 - $51.96 $6,619 - $11,794	227 Added 5.28%	4,528 $137,000
Q4 2020 Feb 12, 2021	SELL	$37.86 - $54.26 $1,552 - $2,224	-41 Reduced 0.94%	4,301 $212,000
Q3 2020 Nov 13, 2020	SELL	$35.13 - $43.62 $46,266 - $57,447	-1,317 Reduced 23.27%	4,342 $166,000
Q2 2020 Aug 14, 2020	BUY	$23.66 - $49.53 $26,901 - $56,315	1,137 Added 25.14%	5,659 $244,000
Q1 2020 May 14, 2020	SELL	$14.39 - $35.8 $15,498 - $38,556	-1,077 Reduced 19.24%	4,522 $118,000
Q4 2019 Feb 13, 2020	BUY	$23.81 - $33.78 $52,548 - $74,552	2,207 Added 65.06%	5,599 $175,000
Q2 2019 Aug 14, 2019	BUY	$19.51 - $28.31 $45,224 - $65,622	2,318 Added 215.83%	3,392 $78,000
Q4 2018 Feb 15, 2019	BUY	$15.41 - $28.92 $16,550 - $31,060	1,074 New	1,074 $22,000

Others Institutions Holding YMAB

# of Institutions

106

Shares Held

24.5M

Call Options Held

40.3K

Put Options Held

400

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $487M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Y M Abs Therapeutics, Inc. Transaction History